Madhi SA, Simoes EAF, Acevedo A, Novoa Pizarro JM, et al. A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants. J Infect Dis 2025;231:e478-e487.
PMID: 39601265